Phase 1 Study of Two Merozoite Surface Protein 1 (MSP1(42)) Vaccines for Plasmodium falciparum Malaria

OBJECTIVES: To assess the safety and immunogenicity of two vaccines, MSP1(42)-FVO/Alhydrogel and MSP1(42)-3D7/Alhydrogel, targeting blood-stage Plasmodium falciparum parasites. DESIGN: A Phase 1 open-label, dose-escalating study. SETTING: Quintiles Phase 1 Services, Lenexa, Kansas between July 2004...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Malkin, Elissa, Long, Carole A, Stowers, Anthony W, Zou, Lanling, Singh, Sanjay, MacDonald, Nicholas J, Narum, David L, Miles, Aaron P, Orcutt, Andrew C, Muratova, Olga, Moretz, Samuel E, Zhou, Hong, Diouf, Ababacar, Fay, Michael, Tierney, Eveline, Leese, Philip, Mahanty, Siddhartha, Miller, Louis H, Saul, Allan, Martin, Laura B
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2007
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1847697/
https://ncbi.nlm.nih.gov/pubmed/17415408
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pctr.0020012
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items